Home health and hospice company Amedisys Inc. reported its third-quarter earnings remained flat at $8.4 million, or 25 cents per share, compared to $8.4 million, or 26 cents per share, a year ago.

The company’s revenue grew 8.7 percent to $326.5 million.

Stock analysts surveyed by Thomson Reuters had forecast earnings of 33 cents per share.

However, Amedisys’ third-quarter results were lowered by $3.1 million, or 9 cents per share, by a number of items including a write-off of costs associated with issuing debt, expenses for a new software system and an asset impairment charge, part of a write-off of an in-house software system.

Without those fees, and other adjustments, Amedisys earned $11.5 million, or 34 cents per share for the quarter.